MedTrace Logo

Effect of Propofol on Postoperative Nausea and Vomiting.

NCT05071794 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-01-31

No results posted yet for this study

Summary

As PONV is an unpleasant experience that badly affects the patients' quality of life after surgery and the anti-emetic effects of propofol have been seldomly studied in Pakistan, this study aims at investigation of the beneficial effects of propofol in reducing the occurrence of PONV.

Conditions

  • Postoperative Nausea and Vomiting

Interventions

DRUG

Propofol

Antiemetic effect of propofol

DRUG

saline 0.9%

Placebo

Sponsors & Collaborators

  • Pakistan Air Force (PAF) Hospital Islamabad

    lead OTHER

Principal Investigators

  • ATIF NAZIR, MD · PAF Hospital Islamabad

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2021-10-29
Completion
2022-10-29

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05071794 on ClinicalTrials.gov